Lataa...
CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma (NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL involves chemotherapy or a combination of chemotherapy and targeted drugs. CD56 expression is considered as an indicator of p...
Tallennettuna:
| Julkaisussa: | J Int Med Res |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218936/ https://ncbi.nlm.nih.gov/pubmed/32363958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520918087 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|